Provided by Tiger Trade Technology Pte. Ltd.

Regenxbio

9.66
+0.29003.09%
Post-market: 9.65-0.0100-0.10%19:56 EDT
Volume:1.75M
Turnover:16.79M
Market Cap:637.69M
PE:-2.57
High:10.10
Open:10.00
Low:9.21
Close:9.37
52wk High:16.19
52wk Low:5.46
Shares:66.01M
Float Shares:57.34M
Volume Ratio:0.85
T/O Rate:3.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7652
EPS(LYR):-3.7593
ROE:-137.63%
ROA:-21.20%
PB:8.89
PE(LYR):-2.57

Loading ...

Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and RegenXBio (RGNX)

TIPRANKS
·
Aug 03

These 7 Small Caps Are on Fire as the Second Half Begins: Here’s Why

Benzinga_recent_news
·
Jul 22

Regenxbio presents long-term data for surabgene lomparvovec

TIPRANKS
·
Jul 19

Regenxbio Presents Positive Long-term Data for Surabgene Lomparvovec in Wet Amd and Diabetic Retinopathy at American Society of Retina Specialists Annual Meeting

THOMSON REUTERS
·
Jul 19

Regenxbio Reports 5-year Wet AMD Efficacy Data for Sura-vec Gene Therapy at ASRS Meeting

Reuters
·
Jul 19

Regenxbio Tumbles on Deep-discounted $100 Mln Equity Offering

Reuters
·
Jul 17

Top Premarket Decliners

MT Newswires Live
·
Jul 17

Regenxbio Prices 1,111,111 Pre-funded Warrants at USD 9 in Public Offering

Reuters
·
Jul 17

Regenxbio - Offering Expected to Close on July 20, 2026

THOMSON REUTERS
·
Jul 17

Regenxbio - Prices Public Offering of 10 Mln Shares at $9 and 1.11 Mln Pre-funded Warrants at $9

THOMSON REUTERS
·
Jul 17

Regenxbio - Expects Gross Proceeds of About $100 Mln from Offering

THOMSON REUTERS
·
Jul 17

Stocks to Watch: Netflix, Spacex, Alcoa, Regenxbio

Dow Jones
·
Jul 17

Regenxbio Slides on Plan to Offer $100M of Stock

Dow Jones
·
Jul 17

Regenxbio Shares Down 16.7% After the Bell; Announces Proposed $100 Mln Common Stock Public Offering

THOMSON REUTERS
·
Jul 17

REGENXBIO Announces Proposed $100 Million Public Stock Offering

MT Newswires Live
·
Jul 17

Regenxbio announces $100M common stock offering

TIPRANKS
·
Jul 17

Regenxbio Plans USD 100 Million Common Stock Offering to Raise Capital

Reuters
·
Jul 17

Regenxbio Announces Proposed Public Offering of Common Stock

THOMSON REUTERS
·
Jul 17

Regenxbio CMO Steve Pakola Sells 2,161 Shares Worth $29,479.04

Reuters
·
Jul 07

Regenxbio Chief Medical Officer Steve Pakola Sells USD 695,992 of Common Shares

Reuters
·
Jul 02